Stay updated on Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial
Sign up to get notified when there's something new on the Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial page.

Latest updates to the Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial page
- Check7 days agoChange DetectedA new revision entry v3.4.3 was added to the study record history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA minor revision update is shown: from Revision: v3.4.1 to v3.4.2 in the history section, with no changes to study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded version v3.4.1 for the CASPAR study with updates to Contacts/Locations, Conditions, Oversight, Study Status, and Study Identification. The older funding notice (v3.4.0, 2025-01-15) was removed.SummaryDifference1%

- Check42 days agoChange DetectedThe page adds UI elements like a glossary toggle and color-coded change highlights, along with notices and a new revision banner. The underlying study data and functionality remain unchanged.SummaryDifference1%

- Check57 days agoChange DetectedA new revision entry v3.3.4 was added to the study record history, and the previous entry v3.3.3 was removed. These updates affect only revision metadata and do not modify the study’s design, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThese are administrative changes to the Record History (added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2) and do not modify study data or primary page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib+Enzalutamide vs Enzalutamide in Metastatic Prostate Ca Clinical Trial page.